{"cdcTestId":"2013-0606","testcaseName":"Dose 1 to dose 2 interval 28-4 days","vaccineGroup":"PCV","evaluationTestType":"Interval: At Absolute Minimum","forecastTestType":"Recommended based on age","assessmentDate":"2020-08-13T00:00:00","patient":{"dob":"2020-05-20T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2020-07-20T00:00:00","vaccineName":"PREVNAR 13","cvx":"133","mvx":"PFR","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2020-08-13T00:00:00","vaccineName":"PREVNAR 13","cvx":"133","mvx":"PFR","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"3","earliestDate":"2020-09-10T00:00:00","recommendedDate":"2020-11-20T00:00:00","pastDueDate":"2021-01-16T00:00:00"},"doses":[{"dateAdministered":"2020-07-20T00:00:00","vaccineName":"PREVNAR 13","cvx":"133","mvx":"PFR","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2020-08-13T00:00:00","vaccineName":"PREVNAR 13","cvx":"133","mvx":"PFR","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2020-05-29T07:39:35.912","generalDescription":"This test case describes when dose #1 and dose #2 of the Pnuemococal 13 vaccine is administered at  28 - 4 days that the second dose is considered to be valid.","changedInVersion":"1.0","reasonForChange":""}